Cochrane · systematic review · CD015196
Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia
Taylor-Rowan, M, Kraia, O, Kolliopoulou, C, et al. · Cochrane Database of Systematic Reviews · 2022 · Cochrane Library
Dementia and Cognitive ImprovementAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
2
current version
GRADE rated
1
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 1 · 50%Very low 1 · 50%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Summary of findings
Population: older adults with cognitive impairment at baseline
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Cognitive decline | no estimate extracted | 10 studies · 18213 participants | Very low Downgraded: risk of bias, inconsistency, publication bias |
Neuropsychiatric outcomes | no estimate extracted | 0 participants | Ungraded |